| Autor: |
Marks, R., Lorenz, K., Trepel, M., Rank, A., Illerhaus, G., Pelz, H., Scholz, C., Duyster, J., Strüßmann, T. |
| Předmět: |
|
| Zdroj: |
Hematological Oncology; Jun2023 Supplement 1, Vol. 41, p425-426, 2p |
| Abstrakt: |
B Results: b From 2016 to 2021 we included 51 patients in our analysis (23 and 10 patients in the prospective multicenter trial cohort 1 and 2, respectively; 18 patients in the retrospective analysis). Pixantrone containing R-CPOP as firstline treatment in elderly DLBCL patients with congestive heart failure or high risk of anthracycline induced cardiotoxicity B Background: b R-CHOP remains the standard of care for fit patients with DLBCL up to 80 years. [Extracted from the article] |
| Databáze: |
Complementary Index |
| Externí odkaz: |
|
Plný text